Fickenscher James E
Insider CIK 1327442 · ATRS Senior Vice President & CFO · AUXL Chief Financial Officer · ZYNE Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 125,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 425,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-10-10 | 2023-10-11 | 170,000 | — | $0 | 425,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 123,087 | — | $0 | 255,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-09-13 | 2023-09-14 | 8,998 | $1.33 | $12.0K | 378,087 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-09-12 | 2023-09-14 | 31,200 | — | $0 | 387,085 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-08 | 2023-02-09 | 6,544 | $0.60 | $3.9K | 355,885 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-02-07 | 2023-02-09 | 22,547 | — | $0 | 362,429 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-01 | 2023-02-02 | 5,927 | $0.60 | $3.6K | 339,882 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-31 | 2023-02-02 | 21,073 | — | $0 | 345,809 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-24 | 2023-01-25 | 170,000 | — | $0 | 324,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-01-23 | 2023-01-25 | 17,769 | $0.60 | $10.7K | 154,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-07-19 | 2022-07-20 | 6,013 | $1.10 | $6.6K | 172,505 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-07-18 | 2022-07-20 | 20,800 | — | $0 | 178,518 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-01-26 | 2022-01-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-01-26 | 2022-01-28 | 85,000 | — | $0 | 157,718 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-01-21 | 2021-01-25 | 78,000 | — | $0 | 78,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-01-21 | 2021-01-25 | 52,000 | — | $0 | 72,718 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-28 | 88,099 | — | $0 | 88,099 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-08-06 | 2018-08-07 | 8,518 | $5.97 | $50.9K | 20,718 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-11 | 2018-01-16 | 67,500 | — | $0 | 67,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-05-12 | 2017-05-16 | 5,200 | $19.82 | $103.1K | 12,200 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 31,350 | — | $0 | 31,350 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2016-12-07 | 2016-12-08 | 4,000 | $14.03 | $56.1K | 7,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2016-12-06 | 2016-12-08 | 3,000 | $14.15 | $42.5K | 3,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2016-09-13 | 2016-09-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 257,900 | — | $0 | 257,900 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2016-06-02 | 2016-06-06 | 121,050 | $1.12 | $135.6K | 391,266 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-21 | 135,000 | $0.72 | $97.2K | 270,216 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 193,241 | — | $0 | 193,241 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2015-05-28 | 2015-06-01 | 95,216 | — | $0 | 135,216 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-03-10 | 2015-03-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-12-11 | 2014-12-15 | 40,000 | $2.50 | $100.0K | 40,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-11-20 | 2014-11-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-06-21 | 2014-06-23 | 80 | $21.18 | $1.7K | 68,603 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 37,000 | — | $0 | 37,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-18 | 2014-02-20 | 668 | $28.30 | $18.9K | 48,683 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 15,000 | — | $0 | 63,683 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 6,375 | — | $0 | 49,351 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-03-12 | 15,000 | — | $0 | 63,683 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-07 | 2014-02-11 | 2,156 | $23.68 | $51.1K | 42,976 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2013-12-11 | 2013-12-12 | 71,067 | — | $0 | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2013-12-11 | 2013-12-12 | 71,067 | $4.78 | $339.7K | 116,199 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2013-12-11 | 2013-12-12 | 71,067 | $20.37 | $1.45M | 45,132 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-06-21 | 2013-06-25 | 80 | $17.15 | $1.4K | 45,132 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2014-03-12 | 15,200 | — | $0 | 45,694 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2013-02-07 | 2013-02-11 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-02-07 | 2013-02-11 | 482 | $18.30 | $8.8K | 45,212 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 3,940 | — | $0 | 30,494 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 15,200 | — | $0 | 45,694 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2012-06-21 | 2012-06-25 | 750 | — | $0 | 26,554 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2012-02-28 | 2012-03-01 | 1,053 | $20.07 | $21.1K | 25,786 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2012-02-14 | 2012-02-16 | 57,000 | — | $0 | 57,000 | SEC↗ |